Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

146
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
146
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

144
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
144
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

122
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
122
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

204
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
204
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

194
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
194
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

117
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
117

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Energy-storage and self-healing microcapsules for secondary batteries: from preparation methods and electrochemical performance to enhancement mechanisms.

Chemical communications (Cambridge, England)·2026
Same author

Effect of high glucose on the gene expression profiling in cardiac fibroblasts from rats at different ages.

PeerJ·2026
Same author

Tumor Immune Microenvironment and Clinicopathological Characteristics of Thoracic NUT Carcinoma.

Laboratory investigation; a journal of technical methods and pathology·2026
Same author

Pyridine-Bridged Axial Coordination Creates Electron-Deficient Co-N<sub>5</sub> Porphyrin Sites for Selective Photoelectrochemical CO<sub>2</sub> Reduction on Si Nanowires.

The journal of physical chemistry letters·2026
Same author

Multifunctional shape-memory BER@GBP sponges for rapid non-compressible hemostasis and accelerated wound healing.

Biomaterials science·2026
Same author

Correction to "A Dual-Interaction Supramolecular Hydrogel System for siRNA Delivery to Enhance Endometrial Receptivity in Stem Cell Therapy".

Biomacromolecules·2026

Related Experiment Video

Updated: Dec 3, 2025

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.1K

Mid-Term Outcome after Tricuspid Valve Replacement.

Yanmei Cheng1, Shaoyan Mo2, Keke Wang2

  • 1The First Affiliated Hospital of Sun Yat-sen University Department of Cardiothoracic Surgery ICU Guangzhou People's Republic of China Department of Cardiothoracic Surgery ICU, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.

Brazilian Journal of Cardiovascular Surgery
|October 29, 2020
PubMed
Summary

Mid-term survival after tricuspid valve replacement (TVR) is significantly impacted by pre-operative cardiac function and post-operative needs for continuous renal replacement therapy (CRRT) or intra-aortic balloon pump (IABP) support.

Keywords:
Cardiac Surgical ProceduresConfidence IntervalsIntra-Aortic Balloon PumpingRisk factorsSurvival RateTricuspid Valve

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.9K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.4K

Related Experiment Videos

Last Updated: Dec 3, 2025

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.1K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.9K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.4K

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Research

Background:

  • Tricuspid valve disease often presents with significant comorbidities.
  • Tricuspid valve replacement (TVR) is a complex procedure with variable outcomes.
  • Understanding mid-term survival is crucial for patient management and surgical planning.

Purpose of the Study:

  • To evaluate the mid-term survival rates following tricuspid valve replacement (TVR).
  • To identify risk factors associated with mortality after TVR.
  • To inform clinical decision-making for patients undergoing TVR.

Main Methods:

  • Retrospective analysis of 110 consecutive patients undergoing TVR from 2007 to 2017.
  • Kaplan-Meier survival analysis and log-rank testing were employed.
  • Cox regression analysis identified independent risk factors for mortality.

Main Results:

  • The median survival was 65.81 months.
  • Five-year survival rates were approximately 48%.
  • Advanced New York Heart Association (NYHA) class, need for continuous renal replacement therapy (CRRT), and intra-aortic balloon pump (IABP) use were significant risk factors for mortality.

Conclusions:

  • Impaired pre-operative cardiac function is linked to increased mid-term mortality after TVR.
  • Post-operative need for CRRT or IABP treatment independently predicts higher mid-term mortality.
  • These findings highlight critical factors influencing outcomes in TVR patients.